The International Congress on Antiphospholipid Antibodies (APS) is held every three years to discuss the recent advances and future directions in aPL and Antiphospholipid Syndrome (APS).

This congress is an opportunity for the delegates and industry professionals to exchange the latest basic and clinical practice and interact with new and old colleagues. Pharmaceutical companies, manufacturers of technical equipment and software and publishers are invited to display their products at the industrial exhibition, held as part of congress.

Istanbul Aps International Congress

  • Are you going to exhibit? If you need a Stand Builders in Istanbul, fill out our on-line form and tell us what kind of stand you need. We'll valuate your needs and introduce you to an exclusive selection of local contractors!

Aps International Congress Booth

Why should you participate?

A presence at the Congress is your organization’s opportunity to leverage four days of unparalleled access to a wide potential client base, to inform them about your products and services, and build long-term relationships. It is also a great opportunity for you to:

  • Interact fwith thousands of decision-makers from all around the world;
  • Introduce new products and services to an expert audience;
  • Gain greater visibility for your company;
  • Benefit from an intense media coverage;
  • Generate sales leads and build relationships with prospects;
  • Survey attendees about your new projects;
  • Keep up on the latest industry developments;
  • Position your brand and increase awareness,
  • ... and so much more!

Aps International Congress Stands Turkey

A wide range of topics

The International Congress on Antiphospholipid Antibodies covers a wide range of topics, including:

  • Origin of Antiphospholipid Antibodies
  • Genetics of Antiphospholipid Antibodies and Syndromes
  • Target Cells and Receptors that Interact with Antiphospholipid Antibodies
  • Definition, Epidemiology, and Natural History of Antiphospholipid Syndrome
  • Most Recent Strategies in the Treatment of Thrombosis in General Population
  • Current Treatment Strategies for Obstetric and Non-obstetric Antiphospholipid Syndrome
  • Strengths and Limitations of the Current Classification Criteria
  • Among many others...

Raquel Dias

Editorial Staff in neventum